Bulletin
Investor Alert

Novartis AG ADR

NYS: NVS

GO
/marketstate/country/us

After Hours

NVS
/zigman2/quotes/203243705/composite

$

85.42

Change

+0.99 +1.17%

Volume

Volume 7,085

Oct 23, 2020, 6:25 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203243705/composite

Previous close

$ 84.41

$ 84.43

Change

+0.02 +0.02%

Day low

Day high

$84.12

$84.88

Open
Open: 84.63

52 week low

52 week high

$69.18

$99.84

Open

Market cap

$186.04B

Average volume

1.73M

P/E ratio

26.86

Rev. per Employee

$415,614

EPS

3.14

Dividend

3.09

Div yield

2.38%

Ex dividend date

3/3/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nvs

MarketWatch News on NVS

  1. Why Snap’s Surge Is Good News for Social Media

    9:30 p.m. Oct. 23, 2020

    - Barron's Online

  2. The Pandemic Speeds Up the Health-Care Revolution

    6:01 p.m. Oct. 6, 2020

    - Barron's Online

  3. Gilead reaches $21 billion deal for Immunomedics

    4:30 p.m. Sept. 13, 2020

    - MarketWatch.com

  4. Novartis Stock Should Rise 20%, Analyst Says

    11:28 a.m. Sept. 11, 2020

    - Barron's Online

  5. Stocks Close Mixed as Record Month Comes to a Close

    4:50 p.m. Aug. 31, 2020

    - Barron's Online

  6. Drug maker Teva’s U.S. unit indicted on price-fixing charges

    6:42 p.m. Aug. 25, 2020

    - Brent Kendall

  7. Novartis melanoma treatment disappoints in trial

    1:37 a.m. Aug. 24, 2020

    - MarketWatch.com

  8. Novartis MS drug Kesimpta gets FDA approval

    3:15 a.m. Aug. 21, 2020

    - MarketWatch.com

  9. These Companies Are Seeking a Cure for Sickle Cell

    11:53 a.m. July 25, 2020

    - Barron's Online

  10. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/nvs

Other News on NVS

  1. 7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

    2:05 p.m. Oct. 23, 2020

    - InvestorPlace.com

  2. Is a Beat in Store for Glaxo (GSK) This Earnings Season?

    7:28 a.m. Oct. 23, 2020

    - Zacks.com

  3. Time Is Running Out on Inovio as Other Vaccine Candidates Advance

    2:08 p.m. Oct. 22, 2020

    - InvestorPlace.com

  4. IPO Update: NLS Pharmaceutics Readies $20 Million IPO Plan

    5:34 p.m. Oct. 20, 2020

    - Seeking Alpha

  5. Bristol-Myers' Acquisition of Bluebird Seems to Make Sense

    5:17 p.m. Oct. 20, 2020

    - GuruFocus.com

  6. Foghorn Therapeutics Files Terms For $120 Million IPO

    2:25 p.m. Oct. 19, 2020

    - Seeking Alpha

  7. Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran

    9:55 a.m. Oct. 19, 2020

    - Zacks.com

  8. Top Research Reports for Novartis, Zoom Video & FIS

    1:31 p.m. Oct. 16, 2020

    - Zacks.com

  9. Pfizer, BioNTech Race to Meet Global Covid-19 Vaccine Needs

    4:03 p.m. Oct. 15, 2020

    - Bojan Pancevski

  10. Roche's (RHHBY) 9M20 Sales Affected by COVID-19 Outbreak

    10:18 a.m. Oct. 15, 2020

    - Zacks.com

  11. Gossamer Shares Pummeled on Asthma Study Results

    3:24 p.m. Oct. 13, 2020

    - GuruFocus.com

  12. Sizing Up Sangamo Therapeutics

    7:02 a.m. Oct. 13, 2020

    - Seeking Alpha

  13. Loading more headlines...
/news/pressrelease/company/us/nvs

Press Releases on NVS

  1. Comprehensive non-correlated Novartis $NVS Trading Report

    2:55 p.m. Oct. 24, 2020

    - Stock Traders Daily

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.